LONA
LeonaBio, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$109.72M
P/E Ratio
—
EPS
$-24.70
Beta
2.23
52W High
$14.21
52W Low
$2.20
50-Day MA
$6.73
200-Day MA
$4.99
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About LeonaBio, Inc.
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company is headquartered in Bothell, Washington.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-33.21M |
| Operating Margin | 0.00% |
| Return on Equity | -290.80% |
| Return on Assets | -28.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $5.20 |
| Price-to-Book | 3.87 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.31 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $9.39M |
| Float | $6.41M |
| % Insiders | 4.46% |
| % Institutions | 68.70% |
Analyst Ratings
Consensus ($16.00 target)
2
Buy1
HoldData last updated: 4/8/2026